pqq cofactor has been researched along with monocrotaline in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bharati, P; Gaikwad, AN; Hanif, K; Jagavelu, K; Khandelwal, N; Lone, ZR; Mahapatra, S; Rai, P; Shafiq, M | 1 |
1 other study(ies) available for pqq cofactor and monocrotaline
| Article | Year |
|---|---|
Pyrroloquinoline quinone (PQQ) improves pulmonary hypertension by regulating mitochondrial and metabolic functions.
Topics: Animals; Endothelial Cells; Humans; Hypertension, Pulmonary; Inflammation; Monocrotaline; PQQ Cofactor; Pulmonary Artery; Rats; Rats, Sprague-Dawley | 2022 |